These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 4149321

  • 21. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L, Lundgren Y, Folkow B.
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract] [Full Text] [Related]

  • 22. Cardiovascular response to adrenergic stimulation during treatment with tertatolol. A new non-cardioselective beta-blocking agent in primary hypertensive patients.
    Fasano ML, Gaeta I, De Simone G, Iannuzzi R, Ferrara LA.
    Jpn Heart J; 1991 Jul; 32(4):435-44. PubMed ID: 1683411
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Acute and subchronic effects of bometolol on blood pressure in hypertensive rats.
    Watanabe TX, Watanabe Y, Hasegawa Y, Kudo Y, Kawashima K, Sokabe H.
    J Pharmacobiodyn; 1981 Jul; 4(7):505-12. PubMed ID: 6117612
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive effect of trimepranol, a new beta-blocking agent.
    Jounela AJ, Pentikäinen PJ, Neuvonen PJ.
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):183-8. PubMed ID: 25847
    [Abstract] [Full Text] [Related]

  • 26. Nitrilophenoxypropanolamines: influence of ring substitution on beta-receptor blockade.
    Mylecharane EJ, Raper C.
    Eur J Pharmacol; 1974 Nov; 29(1):93-101. PubMed ID: 4154862
    [No Abstract] [Full Text] [Related]

  • 27. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A, Gregorini L, Valentini R.
    Cardiology; 1973 Nov; 58(6):369-75. PubMed ID: 4153721
    [No Abstract] [Full Text] [Related]

  • 28. Pafenolol, a new beta 1-selective blocking agent, in mild hypertension. Result of an inpatient study and a subsequent outpatient follow-up.
    Sigurdsson JA, Bengtsson C, Bjurö T.
    Eur J Clin Pharmacol; 1984 Nov; 26(5):549-53. PubMed ID: 6147255
    [Abstract] [Full Text] [Related]

  • 29. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
    Zakhari S.
    Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
    [No Abstract] [Full Text] [Related]

  • 30. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A, Hany S, Bättig B, Jenni R, Troesch M, Willimann P, Graf A, Leutenegger F, Angehrn V, Beck G.
    Schweiz Rundsch Med Prax; 1988 Oct 11; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract] [Full Text] [Related]

  • 31. [Evaluation of hypotensive effect of nadolol].
    Cybulska I, Brym E, Czerniewska E, Wołyńczyk-Niegowska J.
    Pol Arch Med Wewn; 1980 Dec 11; 64(6):475-80. PubMed ID: 6111065
    [No Abstract] [Full Text] [Related]

  • 32. Short- and long-term studies of bucindolol in mild to moderate hypertension: efficacy, safety, and exercise responses.
    Rosendorff C, Goodman C, Coull A.
    J Clin Pharmacol; 1985 Apr 11; 25(3):233-6. PubMed ID: 2860134
    [No Abstract] [Full Text] [Related]

  • 33. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
    Smith SA, Littler WA.
    Clin Exp Pharmacol Physiol; 1988 Apr 11; 15(4):327-31. PubMed ID: 2908433
    [Abstract] [Full Text] [Related]

  • 34. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL, Vukovich RA, Dennick LG, Groel JT, Willard DA.
    Clin Pharmacol Ther; 1980 Jan 11; 27(1):57-63. PubMed ID: 6101312
    [Abstract] [Full Text] [Related]

  • 35. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P, Omvik P, Nordrehaug JE, White W.
    J Cardiovasc Pharmacol; 1992 Jan 11; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [Abstract] [Full Text] [Related]

  • 36. Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension.
    Frithz G, Weiner L.
    Eur J Clin Pharmacol; 1987 Jan 11; 32(1):77-80. PubMed ID: 2884116
    [Abstract] [Full Text] [Related]

  • 37. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
    Hara Y, Nakahara H, Miyagishi A, Nakatani H.
    Nihon Yakurigaku Zasshi; 1983 Aug 11; 82(2):103-16. PubMed ID: 6198264
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
    Mayer O, Petrlík M, Vitous J, Cepelák V.
    Vnitr Lek; 1976 Nov 11; 22(11):1102-9. PubMed ID: 12612
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z, Robak J, Kostka-Trabka E, Grodzińska L, Górka Z, Gryglewski R.
    Folia Biol (Krakow); 1974 Nov 11; 22(2):217-28. PubMed ID: 4151603
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.